Kari Edling
Endocrinology, Diabetes & Metabolism · Phoenix, AZNPI 1295987089
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (58.4%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Lilly USA, LLC at 48.7% of the total. Reporting peaked in 2019 at $16,539 and has fallen 99.7% since, to $50 in 2023.
Across 200 payments — averaging $114.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$11K
- Boehringer Ingelheim$8K
- Novo Nordisk$2K
- Amgen$266
- AstraZeneca$218
- Corcept Therapeutics$217
- plus $1K from 22 others
What the payments were for
- Consulting fees$4,41019%
- Speaking & faculty fees$13,41358%
- Travel & lodging$1,7928%
- Food & beverage$3,34915%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 55 | $11,188 |
| Boehringer Ingelheim | 27 | $8,159 |
| Novo Nordisk | 11 | $1,637 |
| Amgen(2 entities) | 9 | $266 |
| AstraZeneca(2 entities) | 8 | $218 |
| Corcept Therapeutics | 14 | $217 |
| Sanofi-aventis U.S. LLC | 13 | $194 |
| Insulet Corporation | 7 | $140 |
| Mannkind Corporation | 9 | $109 |
| Abbott | 6 | $102 |
| Johnson & Johnson | 6 | $97 |
| Ferring Pharmaceuticals Inc. | 4 | $79 |
| AbbVie | 4 | $74 |
| Amneal Pharmaceuticals LLC | 4 | $64 |
| Pfizer | 3 | $62 |
| Tandem Diabetes Care, Inc. | 2 | $54 |
| Vivus LLC | 3 | $42 |
| Radius Health, Inc. | 2 | $35 |
| IBSA Pharma Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| Companion Medical, Inc. | 2 | $33 |
| Shire North American Group Inc | 2 | $33 |
| Endo Pharmaceuticals Inc. | 1 | $22 |
| Lifescan, Inc. | 1 | $21 |
| Antares Pharma, Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $14 |
| Valeritas, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,972 in reported general payments places this provider in the 85th percentile of 148 endocrinology, diabetes & metabolism providers in Arizona.
See all endocrinology, diabetes & metabolism providers in Arizona →
Other endocrinology, diabetes & metabolism in Phoenix
- Kevin YuenPhoenix$404K
- Joan BaileyPhoenix$316K
- Anna BoronPhoenix$32K
- James DeerPhoenix$13K
- Lory BarazPhoenix$10K
- Sathya JyothinagaramPhoenix$10K
- Philip LevyPhoenix$9K
- Richard ArakakiPhoenix$6K
- Yasmin AkhunjiPhoenix$5K
- Ahmad Al MaradniPhoenix$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.